Table 2.
Incubation of E6 cells with E2-3,4-Q alone or in the presence of NAcCys1
| E2-3,4-Q alone | E2-3,4-Q: NAcCys (1:0.5) | E2-3,4-Q: NAcCys (1:1) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Detected Compounds2 | 1 | 10 | 30 | 1 | 10 | 30 | 1 | 10 | 30 |
| pmol/10 million cells | |||||||||
| 4-OHE1(E2) | 0.41 ± 0.07 |
1.34 ± 0.16 |
2.35 ± 0.30 |
0.27 ± 0.06 |
0.90 ± 0.05 |
1.50 ± 0.18 |
0.14 ± 0.03 |
0.65 ± 0.06 |
0.92 ± 0.09 |
| 4-OCH3E1(E2) | 60.2 ± 5.45 |
555 ± 29.4 |
1142 ± 74.8 |
48.9* ± 5.89 |
414* ± 29.9 |
761* ± 85.7 |
37.5* ± 2.47 |
264* ± 65.8 |
345* ± 81.3 |
| 4-OHE1(E2)-2-SG | 0.76 ± 0.05 |
6.38 ± 1.0 |
14.9 ± 2.36 |
0.86* ± 0.06 |
7.58 ± 2.26 |
18.5* ± 1.83 |
1.0* ± 0.09 |
8.98* ± 1.48 |
21.8* ± 2.41 |
| 4-OHE1(E2)-2-Cys | 4.52 ± 0.48 |
11.4 ± 0.95 |
32.7 ± 3.43 |
5.18 ± 0.48 |
14.1* ± 1.09 |
41.0* ± 3.23 |
6.27* ± 0.67 |
16.8* ± 1.35 |
48.2* ± 3.17 |
| 4-OHE1(E2)-2-NAcCys | 1.80 ± 0.37 |
8.53 ± 0.96 |
18.6 ± 3.26 |
2.30 ± 0.46 |
11.6 ± 2.74 |
28.5* ± 3.28 |
2.85* ± 0.40 |
15.2* ± 2.29 |
42.6* ± 2.08 |
| 4-OHE1(E2)-1-N3Ade | 0.49 ± 0.06 |
2.92 ± 0.27 |
6.22 ± 0.59 |
0.41 ± 0.04 |
2.36 ± 0.58 |
4.37* ± 0.32 |
0.32* ± 0.03 |
1.58* ± 0.16 |
1.86* ± 0.35 |
| 4-OHE1(E2)-1-N7Gua | 0.47 ± 0.08 |
2.76 ± 0.15 |
5.82 ± 0.54 |
0.39 ± 0.02 |
2.07* ± 0.36 |
3.94* ± 0.74 |
0.33* ± 0.02 |
1.42* ± 0.25 |
1.79* ± 0.21 |
E6 cells were incubated at 37 °C for 24 h with E2-3,4-Q (1, 10, or 30 µM) alone or in the presence of different ratios of NAcCys.
The compounds were identified and quantified by HPLC-ECD and the adducts were confirmed by UPLC-MS/MS; values are an average of three replicates from three independent pools of medium each from a set of five flasks; ± standard deviation.
The value is significantly different from th at in the cell s not treated with NAcCys (p<0.05) as determined by the t-test.